Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Adenovirus E1A: remodelling the host cell, a life or death experience

Oncogene volume 20, pages 7824–7835 (2001)Cite this article

It came as a considerable surprise to virologists in 1962 when John Trentin and his colleagues (Trentin et al., 1962) reported that a human adenovirus was oncogenic. At Baylor University (Houston, Texas) they had been inoculating newborn hamsters with human adenoviruses and found that adenovirus serotype 12 (Ad12) induced tumours in a high proportion of the animals injected. Other Ad serotypes (Ads) were found to be non-tumorigenic (this included Ad2, which with its closely related non-oncogenic serotype Ad5, have been the most extensively studied Ads; referred to in this review as Ad2/5). This important observation was initially greeted with some scepticism (see Gross, 1996). However, Ad12 oncogenesis was rapidly confirmed by others (Huebner et al., 1962) and lead to more extensive in vivo and in vitro studies on the capacity of human Ads to disrupt normal cell growth control. It is not possible to review all of the literature on this subject here but there are a number of reviews that cover this subject (Gross, 1996; Gallimore et al., 1984; Williams et al., 1995). From the in vivo studies in the 1960's it soon became clear that there were indeed tumorigenic (Huebner et al., 1962; Trentin et al., 1962, Girardi et al., 1964; Pereira et al., 1965) and non-tumorigenic adenoviruses (Trentin et al., 1962, 1968). As well as Ad serotype, adenovirus induced tumorigenicity was found to be dependent on virus dose (Yabe et al., 1962), host genetic constitution (Yabe et al., 1964, Yohn et al., 1965; Allison et al., 1967), age at inoculation (Yabe et al., 1962) and the host's immune status (Yohn et al., 1965; Allison et al., 1967). Around this time tissue culture studies revealed that rodent cells were susceptible to adenovirus transformation and that both tumorigenic (McBride and Wiener, 1964) and non-tumorigenic Ads (Freeman et al., 1967) induced morphological transformation from which immortal cell lines could be easily derived. Studies on immortal rodent cell lines showed that the cells transformed by non-oncogenic viruses could be tumorigenic, but only in immunocompromised hosts (Gallimore, 1972, Gallimore et al., 1977).

The next logical step in adenovirus research was to identify the virus genes responsible for transformation and/or tumorigenicity. Unlike today, no restriction enzymes were readily available and there was no Southern blotting technique (Southern, 1975). Fujinaga and Green used membrane hybridization to show that adenovirus sequences were indeed retained and expressed in Ad transformed cells (Fujinaga and Green, 1970). This was followed by the first attempt to utilize restriction endonucleases and Cot analysis (Pettersson and Sambrook, 1973) to map the viral sequences in an Ad2 transformed line, Ad2/8617. In the following year, a more extensive study found that a minimal region of the virus genome representing the left hand 14% was common to nine independently isolated Ad2 transformed rat embryo cell lines (Gallimore et al., 1974). This strongly suggested, but did not prove, that the Ad transforming gene resided in this region of the Ad genome. With the development of the calcium phosphate DNA transfection technique (Graham and van der Eb, 1973) and the use of defined Ad DNA fragments, it was convincingly shown that this region was responsible for the induction of transformation (Graham et al., 1974a,b). RNA mapping was carried out (Sharp et al., 1974; Flint et al., 1975) which defined the early region transcripts (reviewed by Shenk and Flint, 1991; Shenk, 1996) and later designated E1 (E1A+E1B) E2, E3 and E4 (Kitchingman et al., 1977). Viral RNA selected on specific Ad DNA fragments was then used in transcription/translation assays to identify the proteins expressed from these regions and their molecular weights (Lewis et al., 1976; Harter and Lewis, 1978; Halbert et al., 1979). The E1A proteins were found to have a molecular weight range from approximately 28 to 58 kDa.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

References

  • Aalfs JD, Kingston RE . 2000 Trends Biochem. Sci. 25: 548–555

  • Ait-Si-Ali S, Ramirez S, Barre FX, Dkhissi F, Magnaghi-Jaulin L, Girault JA, Robin P, Knibiehler M, Pritchard LL, Ducommun B, Trouche D, Harel-Bellan A . 1998 Nature 396: 184–186

  • Allison AC, Berman LD, Levey RH . 1967 Nature 215: 185–187

  • Arany Z, Newsome D, Oldread E, Livingston DM, Eckner R . 1995 Nature 374: 81–84

  • Bannister AJ, Miska EA, Gorlich D, Kouzarides T . 2000 Curr. Biol. 10: 467–470

  • Barbeau D, Charbonneau R, Whalen SG, Bayley ST, Branton PE . 1994 Oncogene 9: 359–373

  • Barker DD, Berk AJ . 1987 Virology 156: 107–121

  • Bayley ST, Mymryk JS . 1994 Intl. J. Oncol. 5: 425–444

  • Berk AJ, Sharp PA . 1978 Cell 14: 695–711

  • Bernards R, Schrier PI, Bos JL, van der Eb AJ . 1983a Virology 127: 45–53

  • Bernards R, Schrier PI, Houweling A, Bos JL, van der Eb AJ, Zijlstra M, Melief CJ . 1983b Nature 305: 776–779

  • Bos JL, Jochemsen AG, Bernards R, Schrier PI, van Ormondt H, van der Eb AJ . 1983 Virology 131: 30–38

  • Boulanger PA, Blair GE . 1991 Biochem. J. 275: 281–299

  • Boyd JM, Subramanian T, Schaeper U, La Regina M, Bayley S, Chinnadurai G . 1993 EMBO J. 12: 469–478

  • Boyer TG, Martin ME, Lees E, Ricciardi RP, Berk AJ . 1999 Nature 399: 276–279

  • Brehm A, Miska EA, McCance DJ, Reid JC, Bannister AJ, Kouzarides T . 1998 Nature 391: 597–601

  • Breiding DE, Edbauer CA, Tong JY, Byrd PJ, Grant RJA, Gallimore PH, Williams J . 1988 Virology 164: 390–402

  • Brown DT, Westphal M, Burlingham BT, Winterhoff U, Doerfler W . 1975 J. Virol. 16: 366–387

  • Buyse IM, Shao G, Huang S . 1995 Proc. Natl. Acad. Sci. USA 92: 4467–4471

  • Byrd PJ, Brown KW, Gallimore PH . 1982 Nature 298: 69–71

  • Byrd PJ, Grand RJ, Gallimore PH . 1988a Oncogene 2: 477–484

  • Byrd PJ, Grand RJA, Breiding D, Williams J, Gallimore PH . 1988b Virology 163: 155–165

  • Ciechanover A . 1998 EMBO J. 17: 7151–7160

  • Chakravarti D, Ogryzko V, Kao H-Y, Nash A, Chen H, Nakatani Y, Evans RM . 1999 Cell 96: 393–403

  • Chan H-M, Krstic-Demonacos M, Smith L, Demonacos C, La Thangue NB . 2001 Nature Cell Biol. 3: 667–674

  • Chatterjee PK, Vayda ME, Flint SJ . 1986 EMBO J. 5: 1633–1644

  • Chatterjee-Kishore M, van Den Akker F, Stark GR . 2000 J. Biol. Chem. 275: 20406–20411

  • Cheung P, Allis CD, Sassone-Corsi P . 2000 Cell 103: 263–271

  • Chiou SK, White E . 1997 J. Virol. 71: 3515–3525

  • Cook JL, May Dl, Lewis Jr AM, Walker TA . 1987 J. Virol. 61: 3510–3520

  • Debbas M, White E . 1993 Genes Dev. 7: 546–554

  • DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, Livingston DM . 1988 Cell 54: 275–283

  • Dery CV, Toth M, Brown M, Horvath J, Allaire S, Weber JM . 1985 J. Gen. Virol. 66: 2671–2684

  • de Stanchina EM, McCurrach ME, Zindy F, Shieh S-Y, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ, Lowe SW . 1998 Genes Dev. 12: 2434–2442

  • Dijkema R, Dekker BMM, van Ormondt H . 1982 Gene 9: 141–156

  • Douglas JL, Gopalakrishnan S, Quinlan MP . 1991 Oncogene 6: 2093–2103

  • Douglas JL, Quinlan MP . 1995 J. Virol. 69: 8061–8065

  • Dumont DJ, Tremblay ML, Branton PE . 1989 J. Virol. 63: 987–991

  • Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP . 1994 Cell 79: 119–130

  • Dyson N, Howley PM, Munger K, Harlow E . 1989 Science 243: 934–937

  • Dyson N . 1998 Genes Dev. 12: 2245–2262

  • Eckner R, Ewen ME, Newsom D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston DM . 1994 Genes Dev. 8: 869–884

  • Fax P, Lipinski KS, Esche H, Brockmann D . 2000a J. Biol. Chem. 275: 8911–8920

  • Fax P, Lehmkuhler O, Kuhn C, Esche H, Brockmann D . 2000b J. Biol. Chem. 275: 40554–40560

  • Fax P, Carlson CR, Collas P, Tasken K, Esche H, Brockmann D . 2001 Virology 285: 30–41

  • Flint SJ, Gallimore PH, Sharp PA . 1975 J. Mol. Biol. 96: 47–68

  • Fraser RA, Rossignol M, Heard DJ, Egly J-M, Chambon P . 1997 J. Biol. Chem. 272: 7122–7126

  • Freeman AE, Black PH, van der Pool EA, Henry PH, Austin JB, Huebner RJ . 1967 Proc. Natl. Acad. Sci. USA 58: 1205–1212

  • Frost E, Williams J . 1978 Virology 91: 39–50

  • Fuchs M, Gerber J, Drapkin R, Sif S, Ikura T, Ogryzko V, Lane WS, Nakatani Y, Livingston DM . 2001 Cell in press

  • Fueyo J, Gomez-Manzano C, Alemany R, Lee PSY, McDonnell TJ, Mitlianga P, Shi Y-X, Levin VA, Yung WKA, Kyritsis A . 2000 Oncogene 19: 2–12

  • Fujinaga K, Green M . 1970 Proc. Natl. Acad. Sci. USA 65: 375–382

  • Fujinaga K, Sawada Y, Uemizu Y, Yamashita T, Shimojo H, Shiroki K, Sugisaki H, Sugimoto K, Takanami M . 1979 Cold Spring Harbor Symp. Quant. Biol. 44: 383–398

  • Furasawa T, Moribe H, Kondoh H, Higashi Y . 1999 Mol. Cell. Biol. 19: 8581–8590

  • Gallimore PH . 1972 J. Gen. Virol. 16: 99–102

  • Gallimore PH, Sharp PA, Sambrook J . 1974 J. Mol. Biol. 89: 49–72

  • Gallimore PH, McDougall JK, Chen LB . 1977 Cell 10: 669–678

  • Gallimore PH, Williams J . 1982 Virology 120: 146–156

  • Gallimore PH, Byrd PJ, Grand RJA . 1984 In: Rigby PWJ, Wilkie NM (eds). ‘Viruses and Cancer’ Symp. Soc. Gen. Microbiol Cambridge University Press, Cambridge pp. 125–172

  • Gallimore PH, Byrd PJ, Whittaker JL, Grand RJA . 1985 Cancer Res. 45: 2670–2680

  • Gayther SA, Batley SJ, Linger L, Bannister A, Thorpe K, Chin S-F, Daigo Y, Russell P, Wilson A, Sowter HM, Delhanty JDA, Ponder BAJ, Kouzarides T, Caldas C . 2000 Nature Genet. 24: 300–303

  • Giradi AJ, Hilleman MR, Zwickey RE . 1964 Proc. Soc. Expt. Biol. Med. 115: 1141–1150

  • Grand RJA, Gallimore PH . 1984 J. Gen. Virol. 65: 2149–2166

  • Grand RJA, Grant ML, Gallimore PH . 1994 Virology 203: 229–240

  • Grand RJA . 2001 In: Grand RJA (ed). Viruses, Cell Transformation and Cancer Elsevier pp. 43–83

  • Graham FL, van der Eb AJ . 1973 Virology 54: 536–539

  • Graham FL, van der Eb AJ, Heijneker HL . 1974a Nature 251: 687–691

  • Graham FL, Abrahams PJ, Mulder C, Heijneker HL, Warnaar SO, de Vries FAJ, Fiers W, van der Eb AJ . 1974b Cold Spring Harbor Symp. Quant. Biol. 39: 637–650

  • Graham FL, Smiley J, Russell WC, Nairn R . 1977 J. Gen. Virol. 36: 59–72

  • Graham FL, Harrison T, Williams J . 1978 Virology 86: 10–21

  • Gross L . 1996 Oncogenic Viruses. 2nd edition Pergamon Press pp. 784–815

  • Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX, Kumar S, Howley PM, Livingston DM . 1998 Mol. Cell 2: 405–415

  • Halbert D, Spector D, Roska HJ . 1979 J. Virol. 31: 621–629

  • Hamamori Y, Sartorelli V, Ogryzko V, Puri PL, Wu H-Y, Wang JYJ, Nakatani Y, Kedes L . 1999 Cell 96: 405–413

  • Harlow E, Franza Jr R, Schley C . 1985 J. Virol. 55: 533–546

  • Harter ML, Lewis JB . 1978 J. Virol. 26: 736–749

  • Hateboer G, Hijmans EM, Nooij JB, Schlenker S, Jentsch S, Bernards R . 1996 J. Biol. Chem. 271: 25906–25911

  • Honda R, Yasuda H . 1999 EMBO J. 18: 22–27

  • Hoppe T, Matuschewski K, Rape M, Schlenker S, Ulrich HD, Jentsch S . 2000 Cell 102: 577–586

  • Houweling A, van den Elsen PJ, van der Eb AJ . 1980 Virology 105: 537–550

  • Huebner RJ, Rowe WP, Laue WT . 1962 Proc. Natl. Acad. Sci. USA 48: 2051–2058

  • Ishimi Y . 1997 J. Biol. Chem. 272: 24508–24513

  • Jacobson S, Pillus L . 1999 Curr. Opin. Genet. Dev. 9: 175–184

  • Jelinek T, Pereira DS, Graham FL . 1994 J. Virol. 68: 888–896

  • Jochemsen AG, Bernards R, van Kranen HJ, Houweling A, Bos JL, van der Eb AJ . 1986 J. Virol. 59: 684–691

  • Jones N, Shenk T . 1978 Cell 13: 181–188

  • Jones N, Shenk T . 1979 Proc. Natl. Acad. Sci. USA 76: 3665–3669

  • Jones N . 1995 Curr. Top. Microbiol. Immunol. 199: 59–80

  • Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L, Gore M, Ironside J, MacDougall RH, Heise C, Randler B, Gillenwater AM, Bruso P, Kaye SB, Hong WK, Kirn DH . 2000 Nature Med. 6: 879–885

  • Kimelman D, Miller JS, Porter D, Roberts BE . 1985 J. Virol. 53: 399–409

  • Kimelman D . 1986 Mol. Cell. Biol. 6: 1487–1496

  • Kirn D . 2000 Oncogene 19: 6660–6669

  • Kitchingman GR, Lai SP, Westphal H . 1977 Proc. Natl. Acad. Sci. USA 74: 4392–4395

  • Köhler A, Cascio P, Leggett DS, Woo KM, Goldberg AL, Finley D . 2001 Mol. Cell 7: 1143–1152

  • Krantz CK, Routes BA, Quinlan MP, Cook JL . 1996 Virology 217: 23–32

  • Kushner DB, Pereira DS, Liu X, Graham FL, Ricciardi RP . 1996 Oncogene 12: 143–151

  • Kushner DB, Ricciardi RP . 1999 Mol. Cell. Biol. 19: 2169–2179

  • Lavau C, Du C, Thirman M, Zeleznik-Le N . 2000 EMBO J. 19: 4655–4664

  • Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD . 1995 Nature 374: 91–94

  • Lei M, Tye BK . 2001 J. Cell. Sci. 114: 1447–1454

  • Lewis JB, Atkins JF, Baum PR, Solem R, Gestland RF, Anderson CW . 1976 Cell 7: 141–151

  • Li Y, Graham C, Lacy S, Duncan AMV, Whyte P . 1993 Genes Dev. 7: 2366–2377

  • Lill NL, Grossman SR, Ginsberg D, DeCaprio JA, Livingston DM . 1997 Nature 387: 823–827

  • Lowe SW, Ruley HE . 1993 Genes Dev. 7: 535–545

  • Lyons RH, Ferguson BQ, Rosenberg M . 1987 Mol. Cell. Biol. 7: 2451–2456

  • Matsumoto K, Okuwaki M, Kawase H, Handa H, Hanaoka F, Nagata K . 1995 J. Biol. Chem. 270: 9645–9650

  • McBride WD, Wiener A . 1964 Proc. Soc. Expt. Biol. Med. 115: 870–874

  • Melhuish TA, Wotton D . 2000 J. Biol. Chem. 275: 39762–39766

  • Molinari E, Gilman M, Natesan S . 1999 EMBO J. 18: 6439–6447

  • Molloy DP, Milner AE, Yakub IK, Chinnadurai G, Gallimore PH, Grand RJA . 1998 J. Biol. Chem. 273: 20867–20876

  • Molloy DP, Smith KJ, Milner AE, Gallimore PH, Grand RJA . 1999 J. Biol. Chem. 274: 3503–3512

  • Moran E . 1994 Semin. Virol. 5: 327–340

  • Muller S, Hoege C, Pyrowolakis G, Jentsch S . 2001 Nat. Rev. Mol. Cell. Biol. 2: 202–210

  • Mymryk JS, Smith MM . 1997 Biochem. Cell. Biol. 75: 95–102

  • Nemunaitis J, Cunningham C, Buchanan A, Blackburn A, Edelman G, Maples P, Netto G, Tong A, Randler B, Olson S, Kirn D . 2001 Gene Ther. 8: 746–759

  • Nibu Y, Zhang H, Levine M . 1998 Science 280: 101–104

  • Pereira DS, Rosenthal KL, Graham FL . 1995 Virology 211: 268–277

  • Pereira MS, Pereira HG, Clarke SKR . 1965 Lancet i: 21–23

  • Perricaudet M, Akusjarvi G, Virtanen A, Pettersson U . 1979 Nature 281: 694–696

  • Pestell RG, Albanese C, Lee RJ, Watanabe G, Moran E, Johnson J, Jameson JL . 1996 Cell Growth Differ. 7: 1337–1344

  • Pettersson U, Sambrook J . 1973 J. Mol. Biol. 73: 125–130

  • Philpott N, Blair GE . 2001 In: Grand RJA (ed). Viruses, Cell Transformation and Cancer Elsevier pp. 413–449

  • Poortinga G, Watanabe M, Parkhurst SM . 1998 EMBO J. 17: 2067–2078

  • Proffitt JL, Blair GE . 1997 FEBS Lett. 400: 141–144

  • Querido E, Teodoro JG, Branton PE . 1997 J. Virol. 71: 3526–3533

  • Raska Jr K, Gallimore PH . 1982 Virology 123: 8–18

  • Rotem-Yehudar R, Winograd S, Sela S, Coligan JE, Ehrlich R . 1994 J. Exp. Med. 180: 477–488

  • Rowe DT, Graham FL, Branton PE . 1983 Virology 129: 456–468

  • Ruley HE . 1983 Nature 304: 602–606

  • Russell WC, McIntosh K, Skehel JJ . 1971 J. Gen. Virol. 11: 35–46

  • Sabbatini P, Lin J-Y, Levine AJ, White E . 1995 Genes Dev. 9: 2184–2192

  • Sarnow P, Ho YS, Williams J, Levine AJ . 1982 Cell 28: 387–394

  • Schaeper U, Boyd JM, Verma S, Uhlmann E, Subramanian T, Chinnadurai G . 1995 Proc. Natl. Acad. Sci. USA 92: 10467–10471

  • Schaeper U, Subramanian T, Lim L, Boyd JM, Chinnadurai G . 1998 J. Biol. Chem. 273: 8549–8552

  • Schrier PI, Bernards R, Vaessen RT, Houweling A, van der Eb AJ . 1983 Nature 305: 771–775

  • Sharp PA, Gallimore PH, Flint SJ . 1974 Cold Spring Harbor Symp. Quant. Biol. 39: 457–474

  • Shenk T, Flint SJ . 1991 Adv. Cancer Res. 57: 47–83

  • Shenk T . 1996 In: Fields Virology, 3rd edn., Fields BN, Knipe DM, Howley PM et al. (eds). Lippincott-Raven Publishers: Philadelphia pp. 2111–2148

  • Smirnov DA, Hou S, Ricciardi RP . 2000 Virology 268: 319–328

  • Smirnov DA, Hou S, Liu X, Claudio E, Siebenlist UK, Ricciardi RP . 2001 Virology 284: 13–19

  • Somasundaram K, El-Deiry WS . 1997 Oncogene 14: 1047–1057

  • Southern EM . 1975 J. Mol. Biol. 98: 503–517

  • Spanò S, Silletta MG, Colanzi A, Alberti S, Fiucci G, Valente C, Fusella A, Salmona M, Mironov A, Luini A, Corda D . 1999 J. Biol. Chem. 274: 17705–17710

  • Spindler KR, Berk AJ . 1984 J. Virol. 52: 706–710

  • Steegenga WT, Shvarts A, Riteco N, Bos JL, Jochemsen AG . 1999 Mol. Cell. Biol. 19: 3885–3894

  • Sterner JM, Dew-Knight S, Musahl C, Kornbluth S, Horowitz JM . 1998 Mol. Cell. Biol. 18: 2748–2757

  • Strober BE, Dunaief JL, Guha S, Goff SP . 1996 Mol. Cell. Biol. 16: 1576–1583

  • Subramanian T, La Regina M, Chinnadurai G . 1989 Oncogene 4: 415–420

  • Sudarsanam P, Winston F . 2000 Trends Genet. 16: 345–351

  • Sugisaki H, Sugimoto K, Takanami M, Shiroki K, Shimojo H, Sawada Y, Uemizu Y, Uesugu S, Fujinaga K . 1980 Cell 20: 777–786

  • Sundqvist A, Sollerbrant K, Svensson C . 1998 FEBS Lett. 429: 183–188

  • Telling GC, Williams J . 1994 J. Virol. 68: 877–887

  • Tremblay ML, McGlade CJ, Gerber GE, Branton PE . 1988 J. Biol. Chem. 263: 6375–6383

  • Trentin JJ, Yabe Y, Taylor G . 1962 Science 137: 835–841

  • Trentin JJ, Van Hoosier GL, Samper L . 1968 Proc. Soc. Expt. Biol. Med. 127: 683–689

  • Trouche D, Kouzarides T . 1996 Proc. Natl. Acad. Sci. USA 93: 1439–1442

  • Turnell AS, Grand RJA, Gallimore PH . 1999 J. Virol. 73: 2074–2083

  • Turnell AS, Grand RJA, Gorbea C, Zhang X, Wang W, Mymryk JS, Gallimore PH . 2000 EMBO J. 19: 4759–4773

  • Urbanelli D, Sawada Y, Raskova J, Jones NC, Shenk T, Raska Jr K . 1989 Virology 173: 607–614

  • van den Elsen PJ, Houweling A, van der Eb AJ . 1983a Virology 131: 242–246

  • van den Elsen PJ, Houweling A, van der Eb AJ . 1983b Virology 128: 377–390

  • van der Eb AJ, van Ormondt H, Schrier PI, Lupker JH, Jockensen H, van den Elsen PJ, DeLeys J, Maat J, van Beveren CP, Dijkema R, de Waard A . 1979 Cold Spring Harbor Symp. Quant. Biol. 44: 383–399

  • van Ormondt H, Maat J, de Waard A, van der Eb AJ . 1978 Gene 4: 309–328

  • van Ormondt H, Maat J, van Beveren CP . 1980 Gene 11: 299–309

  • vom Baur EV, Zechel C, Heery D, Heine MJS, Garnier JM, Vivat U, Le Douarin B, Gronemeyer H, Chambon P, Losson R . 1996 EMBO J. 15: 110–124

  • Weigert R, Silletta MG, Spanò S, Turacchio G, Cericola C, Colanzi A, Senatore S, Mancini R, Polishchuk EV, Salmona M, Facchiano F, Burger KN, Mironov A, Luini, Corda D . 1999 Nature 402: 429–433

  • Whalen SG, Marcellus RC, Barbeau D, Branton PE . 1996 J. Virol. 70: 5378–5383

  • White E . 1998 Semin. Virol. 8: 515–513

  • Whyte P, Buchkovich J, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E . 1988 Nature 334: 124–129

  • Whyte P, Williamson NM, Harlow E . 1989 Cell 56: 67–75

  • Williams J, Williams M, Liu C, Telling G . 1995 Curr. Top. Microbiol. Immunol. 199/III: 149–175

  • Yabe Y, Trentin JJ, Taylor G . 1962 Proc. Soc. Expt. Biol. Med. 111: 343–344

  • Yabe Y, Samper L, Byan E, Taylor G, Trentin JJ . 1964 Science 143: 46–47

  • Yang X-J, Ogryzko VV, Nishikawa J-I, Howard BH, Nakatani Y . 1996 Nature 382: 319–324

  • Yew PR, Berk AJ . 1992 Nature 357: 82–85

  • Yohn DS, Funk CA, Kalruhs VI, Grace JT . 1965 J. Nat. Cancer Inst. 35: 617–624

  • Yu D, Hung M-C . 2000 Oncogene 19: 6115–6121

  • Yu X, Wu LC, Bowcock AM, Aronheim A, Baer R . 1998 J. Biol. Chem. 273: 25388–25392

  • Zaika A, Irwin M, Sansome C, Moll UM . 2001 J. Biol. Chem. 276: 11310–11316

  • Zhang Q, Yao H, Vo N, Goodman RH . 2000 Proc. Natl. Acad. Sci. USA 97: 14323–14328

  • Zhang Z, Smith MM, Mymryk JS . 2001 Mol. Biol. Cell. 12: 699–710

Download references

Acknowledgements

We are extremely grateful to our colleague Roger Grand for his input to this review and to the following for their advice and rapid replies to our e-mails, Arnie Berk, Ron Hay, David Livingston and Joe Mymryk. We are extremely grateful to David Molloy for communicating unpublished data on E1A structure and Miriam Fuchs for information regarding p400. AS Turnell is funded by a Cancer Research Campaign Programme Grant SP19414/2701 and PH Gallimore is a CRC Gibb Fellow.

Author information

Authors and Affiliations

  1. CRC Institute for Cancer Studies, The Medical School, The University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK

    Phillip H Gallimore & Andrew S Turnell

Authors
  1. Phillip H Gallimore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew S Turnell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Phillip H Gallimore.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gallimore, P., Turnell, A. Adenovirus E1A: remodelling the host cell, a life or death experience. Oncogene 20, 7824–7835 (2001). https://doi.org/10.1038/sj.onc.1204913

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204913

Keywords

This article is cited by

Search

Advanced search

Quick links